IFF Swings Open Door On Growing Probiotic Sales After Closing Merger With DuPont Nutrition
Two weeks after merging with probiotic ingredient leader DuPont Nutrition & Biosciences, International Flavors & Fragrances hosts first of two online conferences to help manufacturers and marketers “unlock the power of the microbiome wellness industry."
You may also be interested in...
IFF’s ‘Differentiating’ R&D This Year Includes Probiotics, Biodegradable Fragrance; Q1 Sales Increase 13%
New York firm International Flavors & Fragrances Inc. aims to stand out in 2022 with an R&D pipeline that includes probiotics, plant-based protein and biodegradable fragrances, says CEO Frank Clyburn, speaking in his first quarterly earnings presentation since taking the helm in February.
IFF announces preliminary results of more than 99% of votes approving issuing shares pursuant to an agreement that positions it as acquiring DuPont Nutrition & Biosciences under a “reverse Morris trust” transaction. The merger is between DuPont Nutrition & Biosciences and a subsidiary IFF established as a corporate entity to conduct the transaction.
OTC drug development and marketing consultants spoke with HBW Insight about FDA’s “Nonprescription Drug Product with an Additional Condition for Nonprescription Use” proposed rule. In first of two articles, they discuss proposed rule’s likely impacts on industry and remaining concerns around incorporating extra-label information in drug labeling.